These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19874561

  • 21. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma or 65% platelet additive solution III/35% plasma and including periods without agitation under simulated shipping conditions.
    Moroff G, Kurtz J, Seetharaman S, Skripchenko A, Awatefe H, Thompson-Montgomery D, Myrup A, Wagner SJ.
    Transfusion; 2012 Apr; 52(4):834-43. PubMed ID: 22014086
    [Abstract] [Full Text] [Related]

  • 22. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
    Picker SM, Steisel A, Gathof BS.
    Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of in vitro storage properties of apheresis platelets suspended in a bicarbonate-containing additive solution with low levels of plasma and stored with a 24-hour interruption of agitation.
    Skripchenko A, Turgeon A, Thompson-Montgomery D, Awatefe H, Wagner SJ.
    Vox Sang; 2014 May; 106(4):337-43. PubMed ID: 24330192
    [Abstract] [Full Text] [Related]

  • 24. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
    Sandgren P, Mayaudon V, Payrat JM, Sjödin A, Gulliksson H.
    Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
    [Abstract] [Full Text] [Related]

  • 25. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: Results of a three-arm in vitro study.
    Picker SM, Steisel A, Gathof BS.
    Transfus Apher Sci; 2009 Apr; 40(2):79-85. PubMed ID: 19233725
    [Abstract] [Full Text] [Related]

  • 26. Storage of aliquots of apheresis platelets for neonatal use in syringes with and without agitation.
    Diab Y, Wong E, Criss VR, Moroff G, Wagner SJ, Luban NL.
    Transfusion; 2011 Dec; 51(12):2642-6. PubMed ID: 21745210
    [Abstract] [Full Text] [Related]

  • 27. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
    Zeiler T, Gritzka D, Karger R, Kretschmer V.
    Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
    [Abstract] [Full Text] [Related]

  • 28. A rest period does not affect in vitro storage properties in apheresis platelets collected from the buffy coat layer.
    Wagner SJ, Seetharaman S, Kurtz J.
    Transfusion; 2012 Nov; 52(11):2427-31. PubMed ID: 22452313
    [Abstract] [Full Text] [Related]

  • 29. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A, Kurtz J, Moroff G, Wagner SJ.
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [Abstract] [Full Text] [Related]

  • 30. Impairment of the hemostatic potential of platelets during storage as evaluated by flow cytometry, thrombin generation, and thrombelastography under conditions promoting formation of coated platelets.
    Svendsen MS, Rojkjaer R, Kristensen AT, Salado-Jimena JA, Kjalke M, Johansson PI.
    Transfusion; 2007 Nov; 47(11):2057-65. PubMed ID: 17958535
    [Abstract] [Full Text] [Related]

  • 31. Preparation and storage of white blood cell-reduced split apheresis platelet concentrates for pediatric use.
    van der Meer PF, Vrielink H, Pietersz RN.
    Transfusion; 2005 Feb; 45(2):223-7. PubMed ID: 15660831
    [Abstract] [Full Text] [Related]

  • 32. The maintenance of platelet properties during 20-24 degrees C storage after periods of shipment or interrupted agitation.
    Wagner SJ.
    Transfus Apher Sci; 2010 Feb; 42(1):45-51. PubMed ID: 19931491
    [Abstract] [Full Text] [Related]

  • 33. The effect of interruption of agitation on in vitro measures of platelet concentrates in additive solution.
    van der Meer PF, Liefting LA, Pietersz RN.
    Transfusion; 2007 Jun; 47(6):955-9. PubMed ID: 17524082
    [Abstract] [Full Text] [Related]

  • 34. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R, Fröhlich A, Mayaudon V, Lin L.
    J Clin Apher; 2004 Jun; 19(4):185-91. PubMed ID: 15597347
    [Abstract] [Full Text] [Related]

  • 35. Stored platelets contain residual amounts of tissue factor: evidence from studies on platelet concentrates stored for prolonged periods.
    Pérez-Pujol S, Aras O, Lozano M, Cocking-Johnson D, Key NS, White JG, McCullough J, Escolar G.
    Transfusion; 2005 Apr; 45(4):572-9. PubMed ID: 15819679
    [Abstract] [Full Text] [Related]

  • 36. Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage.
    Li J, Goodrich L, Hansen E, Edrich R, Gampp D, Goodrich RP.
    Transfusion; 2005 Nov; 45(11):1750-8. PubMed ID: 16271100
    [Abstract] [Full Text] [Related]

  • 37. The effect of gamma irradiation on platelet redox state during storage.
    Nodeh FK, Hosseini E, Ghasemzadeh M.
    Transfusion; 2021 Feb; 61(2):579-593. PubMed ID: 33231307
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A, Diedrich B, Falker C, Jansson B, Sandgren P, Sundkvist L, Svensson L, Vesterinen M, Gulliksson H.
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.